ArticleCureus2025
Parathyroid Carcinoma in a Patient With End-Stage Renal Disease Initially Suspected With Refractory Secondary Hyperparathyroidism.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Occult Parathyroid Lesions onBiomedicines · 2026Article
- A patient with CKD complicated by secondary hyperparathyroidism and parathyroid carcinoma: a case report.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 50-year-old woman, who developed end-stage renal failure due to immunoglobulin A (IgA) nephropathy, had been on hemodialysis for seven years. One year ago, she underwent evaluation at another hospital for elevated parathyroid hormone (PTH) levels; however, no definitive diagnosis was made, and she was placed under observation. Because secondary hyperparathyroidism (SHPT) was considered the most likely cause in a dialysis patient, her medications were adjusted, but her PTH levels did not improve, and she was referred to our department. Further evaluation revealed a suspicion of parathyroid carcinoma, and parathyroidectomy was performed. Histopathological examination confirmed the diagnosis of parathyroid carcinoma. Postoperatively, her PTH levels normalized promptly. Although secondary hyperparathyroidism is a common cause of hyperparathyroidism in maintenance dialysis patients, this case suggests the importance of considering parathyroid carcinoma as a possible underlying cause.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.